卵巢储备功能低下女性体外受精周期中低剂量促性腺激素的系统综述与荟萃分析
该系统综述与荟萃分析纳入14项随机对照研究(N=2104),比较低剂量促性腺激素或促性腺激素联合口服药物与高剂量促性腺激素在卵巢储备功能低下女性体外受精/卵胞浆内单精子注射中的效果。主要结局每随机化女性的持续妊娠率在两组间均无显著差异。低剂量方案与联合口服方案从未进行头对头比较,何种更优尚不清楚,需要健康经济学分析。
要点
- 低剂量促性腺激素与高剂量促性腺激素的持续妊娠率无显著差异(RR 0.98,95%CI 0.62-1.57)。
- 促性腺激素联合来曲唑或枸橼酸氯米芬与高剂量促性腺激素的持续妊娠率无显著差异(RR 0.90,95%CI 0.63-1.27)。
- 低剂量方案与联合口服方案从未进行头对头比较,何种更优尚不清楚。
核心结论
- 在卵巢刺激方案中,低剂量促性腺激素及促性腺激素联合口服药物与高剂量促性腺激素相比,妊娠结局无显著差异。
- 低剂量促性腺激素或促性腺激素联合口服药物是否更优尚不清楚,因为二者从未进行头对头比较。
- 需要进行健康经济学分析以检验低剂量卵巢刺激比高剂量促性腺激素更具成本效益的假设。
研究设计与样本
- 系统综述与荟萃分析,纳入评估低剂量促性腺激素单用或联合口服药物与高剂量促性腺激素比较的随机对照研究。
- 检索PubMed、EMBASE、Web of Science、Cochrane图书馆和临床试验注册库,使用医学主题词和自由文本词,截至2016年6月,无语言或年份限制。
- 共检索到787条记录,纳入14项随机对照研究(N=2104名女性)。
- 采用Cochrane协作网推荐标准评估偏倚风险,使用固定效应和随机效应模型进行荟萃分析。
主要发现
- 5项研究(N=717名女性)比较低剂量促性腺激素与高剂量促性腺激素,持续妊娠率无差异证据(2项随机对照研究:风险率0.98,95%置信区间0.62-1.57,I²=0)。
- 9项研究(N=1387名女性)比较促性腺激素联合口服药物来曲唑(n=6)或枸橼酸氯米芬(n=3)与高剂量促性腺激素,持续妊娠率无差异证据(3项随机对照研究:风险率0.90,95%置信区间0.63-1.27,I²=0)。
局限性
- 低剂量促性腺激素或促性腺激素联合口服药物是否更优尚不清楚,因为二者从未进行头对头比较。
- 需要进行健康经济学分析以检验低剂量卵巢刺激比高剂量促性腺激素更具成本效益的假设。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the effectiveness of low doses of gonadotropins and gonadotropins combined with oral compounds compared with high doses of gonadotropins in ovarian stimulation regimens in terms of ongoing pregnancy per fresh IVF attempt in women with poor ovarian reserve undergoing IVF/intracytoplasmic sperm injection (ICSI) treatment. DESIGN: A systematic review and meta-analysis of randomized controlled studies that evaluate the effectiveness of low dosing of gonadotropins alone or combined with oral compounds compared with high doses of gonadotropins in women with poor ovarian reserve undergoing IVF/ICSI treatment. SETTING: Not applicable. PATIENT(S): Subfertile women with poor ovarian reserve undergoing IVF/ICSI treatment. INTERVENTION(S): We searched the PubMed, EMBASE, Web of Science, the Cochrane Library, and the Clinical Trials Registry using medical subject headings and free text terms up to June 2016, without language or year restrictions. We included randomized controlled studies (RCTs) enrolling subfertile women with poor ovarian reserve undergoing IVF/ICSI treatment and comparing low doses of gonadotropins and gonadotropins combined with oral compounds versus high doses of gonadotropins. We assessed the risk of bias using the criteria recommended by the Cochrane Collaboration. We pooled the results by meta-analysis using the fixed and random effects model. MAIN OUTCOMES MEASURE(S): The primary outcome was ongoing pregnancy rate (PR) per woman randomized. RESULT(S): We retrieved 787 records. Fourteen RCTs (N = 2,104 women) were included in the analysis. Five studies (N = 717 women) compared low doses of gonadotropins versus high doses of gonadotropins. There was no evidence of a difference in ongoing PR (2 RCTs: risk rate 0.98, 95% confidence interval 0.62-1.57, I2 = 0). Nine studies (N = 1,387 women) compared ovarian stimulation using gonadotropins combined with the oral compounds letrozole (n = 6) or clomiphene citrate (CC) (n = 3) versus high doses of gonadotropins. There was no evidence of a difference in ongoing PR (3 RCTs: risk rate 0.90, 95% confidence interval 0.63-1.27, I2 = 0). CONCLUSION(S): We found no evidence of a difference in pregnancy outcomes between low doses of gonadotropins and gonadotropins combined with oral compounds compared with high doses of gonadotropins in ovarian stimulation regimens. Whether low doses of gonadotropins or gonadotropins combined with oral compounds is to be preferred is unknown, as they have never been compared head to head. A health economic analysis to test the hypothesis that an ovarian stimulation with low dosing is more cost-effective than high doses of gonadotropins is needed. PROSPERO REGISTRATION NUMBER: CRD42016041301.
引用
- Youssef MA, van Wely M, Mochtar M, et al. Low dosing of gonadotropins in in vitro fertilization cycles for women with poor ovarian reserve: systematic review and meta-analysis. Fertil Steril. 2018. PMID: 29317127. doi:10.1016/j.fertnstert.2017.10.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。